Cyterix Pharmaceuticals Inc. — Form D/A
Cyterix Pharmaceuticals Inc. of REDWOOD CITY, CA, a company, filed a Form D amendment with the SEC on 2011-05-06. The offering totals $7.7M, of which $1.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2011-05-06
- Form: D/A
- Accession: 0001513915-11-000002
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $7.7M
- Amount sold: $1.5M
- Remaining: $6.2M
- Investors: 3
- Date of first sale: 2011-02-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-155865
Issuer
- Name: Cyterix Pharmaceuticals Inc.
- CIK: 0001513915
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 1300 SEAPORT BLVD, SUITE 500, REDWOOD CITY, CA, 94063
- Phone: (650) 474-8251
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Steven Everett | Director | Redwood City, CA |
| Tim Kutzkey | Director | South San Francisco, CA |
| Steven Everett | Executive Officer | Redwood City, CA |
Other filings by this issuer (1)
More